CD10-activated prodrug compounds

Details for Australian Patent Application No. 2002316539 (hide)

Owner Medarex, Inc.

Inventors Nieder, Matthew H.; Cardarelli, Pina M.; Bebbington, Christopher R.; Pickford, Lesley B.; Pan, Chin; Gangwar, Sanjeev

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2002316539

PCT Number PCT/US02/21135

PCT Pub. Number WO2002/100353

Priority 60/297,596 11.06.01 US

Filing date 11 June 2002

Wipo publication date 23 December 2002

Acceptance publication date 1 May 2008

International Classifications

A61K 31/704 (2006.01)

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61K 49/00 (2006.01) Preparations for testing

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/02 (2006.01) Antineoplastic agents

A61P 35/04 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07K 5/06 (2006.01) Peptides having up to four amino acids in a fully defined sequence

C07K 5/083 (2006.01) Peptides having up to four amino acids in a fully defined sequence

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

9 January 2003 Complete Application Filed

  Priority application(s): 60/297,596 11.06.01 US

15 May 2003 Application Open to Public Inspection

  Published as AU-B-2002316539

1 May 2008 Application Accepted

  Published as AU-B-2002316539

19 June 2008 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 02 Jun 2008. Address for service in Australia - Phillips Ormonde & Fitzpatrick Level 22 367 Collins Street Melbourne VIC 3000

4 September 2008 Standard Patent Sealed

30 October 2008 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 02 Jun 2008

19 January 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002316540-METHOD FOR HIGH YIELD PURIFICATION OF IMMUNE GLOBULINS FROM BLOOD PLASMA AND BLOOD PLASMA INTERMEDIATES

2002316538-CONTOURED PALLETIZER LAYER PAD